Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (271 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Dec 2021 – 20 Aug 2026, limited by Axis Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 08 Dec 2021 | ₹100.00 | ₹100.00 |
| 30 Apr 2022 | ₹98.04 | ₹97.90 |
| 20 Sep 2022 | ₹102.91 | ₹101.98 |
| 10 Feb 2023 | ₹103.30 | ₹102.21 |
| 03 Jul 2023 | ₹112.26 | ₹110.61 |
| 23 Nov 2023 | ₹115.56 | ₹113.35 |
| 14 Apr 2024 | ₹131.53 | ₹128.91 |
| 04 Sep 2024 | ₹148.12 | ₹144.24 |
| 25 Jan 2025 | ₹136.08 | ₹132.18 |
| 17 Jun 2025 | ₹147.04 | ₹142.27 |
| 07 Nov 2025 | ₹151.73 | ₹145.92 |
| 30 Mar 2026 | ₹126.23 | ₹127.83 |
| 20 Aug 2026 | ₹137.93 | ₹138.71 |
| Metric | Axis · Direct · IDCW NAV ₹13.99 Very High risk ★★★☆☆ | Category median Index Funds · 271 funds |
|---|---|---|
| -7.37% | +5.06% | |
| +7.00% | +7.78% | |
| — | +8.94% | |
| — | +10.39% | |
| +7.08% | +7.54% | |
| +5.39% | — | |
| +12.11% | +8.12% | |
| — | +12.83% | |
| — | +11.97% | |
| Risk | ||
| 13.34% | 13.54% | |
| 0.04 | 0.16 | |
| 0.05 | 0.22 | |
| -19.44% | -15.77% | |
| Nifty 50 | — | |
| -0.78% | +0.53% | |
| 1.10 | 1.00 | |
| 102.1% | 102.2% | |
| 108.8% | 98.0% | |
| 0.17% | 0.34% | |
| ₹967.79Cr | ₹191.88Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 38% | |
| Karthik Kumar | — | |
| 08 Dec 2021 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.